Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the G-Protein Coupled Receptors Market Growth in 2025?

In recent times, there has been a significant increase in the market size of G-protein coupled receptors. It will escalate from $3.2 billion in 2024 to $3.41 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. This steady growth in the historic period is the result of advancements in drug discovery, approvals from the FDA, genomic breakthroughs, the rise of emerging markets, market consolidation, and a growing aged population.

What Is the Forecast for the G-Protein Coupled Receptors Market Size Through 2029?

The market size for G-protein coupled receptors is projected to witness significant expansion in the coming years, ballooning to $4.46 billion by 2029 with a compound annual growth rate (CAGR) of 7.0%. The expected growth in this period can be credited to factors such as personalized medicine, heightened attention to rare diseases, the role of artificial intelligence in drug discovery, drug development centered around patients, environmental and social influences, and the expansion of the biosimilar market. The forecast period is likely to see major trends like advancements in biotechnology, escalated investment in research and development, breakthroughs in technology, collaborations and partnerships in the sector, and digital therapeutics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp

What are the Key Market Players in G-Protein Coupled Receptors Market and How They’re Evolving?

Major companies operating in the G-protein coupled receptors market include Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Danaher Corporation, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Thermo Fisher Scientific Inc., Perkin Elmer Inc., Qiagen N.V., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Escient Pharmaceuticals Inc., Structure Therapeutics, Septerna

What Are the Primary Growth Drivers in the G-Protein Coupled Receptors Market?

The escalating occurrences of cancer are anticipated to boost the expansion of the G-protein-coupled receptors market in the future. Cancer is a disease characterized by uncontrollably multiplying abnormal cells that can invade and affect neighboring tissues. The dispersion of cancer cells can further occur via the body’s vascular and lymphatic systems. GPCRs regulate the procedures recognized as cancer’s distinctive features, which include proliferative signaling, replicative immortality, circumvention of growth inhibitors, resistance against programmed cell death, and instigation of invasion and metastasis. For instance, the American Cancer Society, a professional organization based in the US, declared in January 2023 that the country saw 1,958,310 newly diagnosed cancer cases in the year 2023, marking an upsurge from the projected 1.9 million fresh cases in 2022. Consequently, the surging frequency of cancer is propelling the expansion of the G-protein-coupled receptors market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11976&type=smp

What Are the Leading Segments in the Global G-Protein Coupled Receptors Industry?

The G-protein coupled receptors market covered in this report is segmented –

1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands

2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding And GTP?S Functional Assays, Internalization Assays, Trafficking Assays

3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications

Subsegments:

1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines

2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays

3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors

4) By Ligands: Agonists, Antagonists, Inverse Agonists

What Are the Key Market Trends in the G-Protein Coupled Receptors Industry?

The escalation of investments to further GPCR screening and antibody creation represents a prominent trend within the G-protein-coupled receptor (GPCR) industry. A multitude of significant companies within the GPCR niche are concentrating their efforts on securing funds needed to progress drug creation and therapeutic technologies, intricately tied to GPCR-related illnesses. For instance, February 2023 signified a sizeable financial commitment from LifeArc Ventures, a UK venture capital company, where $16 million was injected into Maxion Therapeutics, a British pharmaceutical discovery enterprise, to stimulate antibody advancement for previously incurable GPCR and ion channel illnesses. The monetary contribution will facilitate the creation of antibody treatments specifically targeting ion channels and G-protein-coupled receptors (GPCRs), by leveraging the unique KnotBody system. The KnotBody framework allows for the exploration of biologicals against GPCRs and ion channels, relying on naturally existing cysteine-rich mini proteins. Furthermore, Septerna Inc., a BioTech company originating from the US, declared its inauguration and received an impressive Series A financing of $100 million. The amassed Series A funding will be devoted to the evolution of their upcoming pipeline of ground-breaking medication programs, focused on GPCRs, empowered by the Native Complex Platform, and spanning various therapeutic sectors.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report

What Is the Regional Outlook for the G-Protein Coupled Receptors Market?

North America was the largest region in the G-protein coupled receptors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the G-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11976

This Report Delivers Insight On:

1. How big is the g-protein coupled receptors market, and how is it changing globally?

2. Who are the major companies in the g-protein coupled receptors market, and how are they performing?

3. What are the key opportunities and risks in the g-protein coupled receptors market right now?

4. Which products or customer segments are growing the most in the g-protein coupled receptors market?

5. What factors are helping or slowing down the growth of the g-protein coupled receptors market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model